Valuation: Ainos, Inc.

Market Cap 13.48M 11.79M 10.87M 10.06M 19.09M 1.29B 19.41M 130M 51.04M 632M 50.59M 49.5M 2.19B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 24.06M 21.05M 19.41M 17.96M 34.09M 2.3B 34.66M 232M 91.12M 1.13B 90.32M 88.37M 3.91B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
33.62%
Yield 2024 *
-
Yield 2025 -
1 day+3.01%
1 week+0.80%
Current month-2.84%
1 month-7.60%
3 months+11.54%
6 months+1.34%
Current year+14.94%
1 week 1.81
Extreme 1.8136
2.08
1 month 1.72
Extreme 1.72
2.31
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.5
3 years 1.26
Extreme 1.26
30.5
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 72 15/04/2021
Director/Board Member 68 15/06/2022
Director/Board Member 49 15/04/2021
Date Insider Type Main position Quantity % Market Cap.
06-05Buy

Director

3,500 0.0501%
06-03Buy

Director

2,000 0.0286%
05-28Buy

Director

250 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
+3.01%+0.80%-40.91%-89.23% 13.48M
+2.17%-0.48%+24.06%+0.79% 190B
-0.87%-3.21%-21.92%+21.18% 147B
+1.91%-1.75%-3.23%-17.06% 135B
-0.95%-1.30%-56.73%-15.46% 66.6B
-2.62%-3.29%+18.23%-0.41% 53.92B
+0.38%-1.66%-27.47%-30.84% 43.57B
+2.46%+1.27%+9.11%+11.82% 36.45B
+1.74%-1.19%+7.33%+41.61% 36.15B
+0.99%-0.62%-18.61%-3.82% 29.69B
Average +0.84%+0.06%-11.01%-8.14% 73.8B
Weighted average by Cap. +0.72%+1.62%-4.13%+0.52%

Financials

2024 2025
Net sales 20.73K 18.13K 16.72K 15.47K 29.37K 1.98M 29.86K 200K 78.5K 972K 77.82K 76.14K 3.37M 124K 109K 100K 92.67K 176K 11.85M 179K 1.2M 470K 5.82M 466K 456K 20.16M
Net income -14.86M -13M -11.99M -11.09M -21.06M -1.42B -21.41M -144M -56.29M -697M -55.8M -54.59M -2.41B -14.77M -12.92M -11.92M -11.03M -20.93M -1.41B -21.28M -143M -55.94M -692M -55.45M -54.25M -2.4B
Net Debt 8.11M 7.09M 6.54M 6.05M 11.49M 774M 11.68M 78.32M 30.7M 380M 30.43M 29.78M 1.32B 10.58M 9.26M 8.54M 7.9M 14.99M 1.01B 15.24M 102M 40.08M 496M 39.73M 38.87M 1.72B
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
10/07/26 US$1.885 +3.01% 78,012
08/07/26 US$1.830 -2.66% 23,966
07/07/26 US$1.880 -7.84% 68,040
06/07/26 US$2.040 +9.09% 33,131
02/07/26 US$1.870 -8.33% 54,787
  1. Stock Market
  2. Stocks
  3. AIMD Stock